Department of Urology, University of Florida, 1600 SW Archer Road, Gainesville, FL, USA.
Ther Adv Urol. 2009 Dec;1(5):251-8. doi: 10.1177/1756287210364207.
Since it was introduced in 1999, the da Vinci Surgical System has become an integral tool in urologic surgery, specifically in the management of localized prostate cancer. The original technique of robot-assisted laparoscopic prostatectomy (RALP) was developed and standardized in 2000 at the Institut Mutualiste Monsouris. Since that time, the technique of RALP has undergone various modifications. The driving force behind the evolution of the RALP technique in the past decade has been based on efforts to improve upon the three main objectives of surgery, namely the 'trifecta' of cancer cure and the preservation of potency and of urinary continence. In this review, we aim to provide an update on the midterm oncologic outcomes of RALP and focus specifically on two technical modifications that have been introduced in an effort to optimize the outcomes of potency and earlier return of urinary continence.
自 1999 年推出以来，达芬奇手术系统已成为泌尿外科手术的重要工具，特别是在局部前列腺癌的治疗中。机器人辅助腹腔镜前列腺切除术（RALP）的原始技术于 2000 年在蒙苏里互助研究所开发和标准化。从那时起，RALP 技术经历了各种修改。在过去十年中，推动 RALP 技术发展的动力是基于改善手术的三个主要目标，即癌症治愈、保持勃起功能和尿控能力。在这篇综述中，我们旨在提供 RALP 的中期肿瘤学结果的最新信息，并特别关注两项技术改进，这两项改进旨在优化勃起功能和更早恢复尿控能力的结果。
